Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Multiple sclerosis | 29 | 19 | |
Systemic lupus erythematosus | 6 | 5 | |
Improve mobility | 4 | 3 | |
Amyotrophic lateral sclerosis | 2 | 3 | |
Blurry vision | 2 | 1 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Insomnia | 4 | |
Weight gain | 4 | |
Insomnia | 3 | |
Anxious mood | 2 | |
Diarrhea | 2 | |
Rashes (redness, swelling) | 2 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 10 | |
Moderate | 21 | |
Mild | 22 | |
None | 14 |
Member evaluations
AAMS54
evaluated on Mar 20, 2012
- Perceived effectiveness for relapse MS (exacerbation): Moderate
- Side effects: Mild